121.1101-Erectile dysfunction and Cardiovascular disease_Schwartz, Circulation.pdf | 441.63Kb | January 14 2011 |
124.1101-Prevalence of Coronary AthS in patients with cerebral infarction_Amarenco, Stroke.pdf | 583.35Kb | January 14 2011 |
131.1101-Impact of smoking on CV events in patients with CAD receiving contemporary BMT_Frey, Am J Cardiol.pdf | 241.93Kb | January 14 2011 |
133.1101-Early and long-term results of CEA in diabetic patients_Dorigo, jvs.pdf | 137.83Kb | January 14 2011 |
15.1101-Anatomical study of the vessels of the LL using CTA and 3D reconstructions_Chen, Surg Radiol Anat.pdf | 841.82Kb | January 14 2011 |
150.1101-Cardiovascular safety of non-steroidal anti-inflammatory drugs. MA_Trelle, bmj.pdf | 163.03Kb | January 14 2011 |
212.1101-RF for Ischemic stroke and TIA in patients under age 50_Janssen, JTT.pdf | 343.20Kb | January 14 2011 |
265.1101-Dolichoectasia, an evolving arterial disease_Guttierrez, Nat Neurol.pdf | 320.73Kb | January 14 2011 |
274.1102-Contemporary management of concomitant carotid and coronary artery disease_Venkatachalam, Heart.pdf | 141.33Kb | January 14 2011 |
278.1101ep-Risk of recurrent CV event in pateints with cryptogenic stroke or TIA and patent FO_FORI, CVD.pdf | 143.99Kb | January 14 2011 |
311.1101-Use and utility of ABI in patients with diabetes_Potier, ejves.pdf | 169.88Kb | January 14 2011 |
312q.1101-Limitations of self-reported estimates of functional capacity using the WIQ_Mahe, ejves.pdf | 490.50Kb | January 14 2011 |
323.1012ep-Socioeconomic and hospital-related predictors of amputation for CLI_Henry, jvs.pdf | 113.00Kb | January 14 2011 |
331.1101-Cost-effectiveness of exercise therapy in patients with IC. SET vs Go home and Walk advice_van Asselt, ejves.pdf | 328.05Kb | January 14 2011 |
331.1101-Exercise rehabilitation in PAD_Hamburg, Circulation.pdf | 341.09Kb | January 14 2011 |
370.1010-Dg and Management of AAA. Current status and future prospects. Moxon, Curr Probl Cardiol.pdf | 603.37Kb | January 14 2011 |
370.1101-Management of AAA. Clinical pratice guidelines of the ESVS_Moll, ejves.pdf | 1.36Mb | January 14 2011 |
371t.1101-Thrombus volume is associated with CV events and aneurysm growth in patients with AAA_Parr, jvs.pdf | 301.33Kb | January 14 2011 |
376a.1101-1 Rupture rates of small AAA. Systematic review of the literature_Powell, ejves.pdf | 238.55Kb | January 14 2011 |
376a.1101-2 Rupture in small AAA. Beyond the rates ... Comment_De Rango, ejves.pdf | 90.49Kb | January 14 2011 |
376a.1101-a Comparison of surveillance vs EVAR for small AAA. CAESAR RCT_Cao, ejves.pdf | 731.67Kb | January 14 2011 |
376a.1101-b CAESAR trial. Highlighting the need for different endpoints. Comment_Bicknell, ejves.pdf | 120.19Kb | January 14 2011 |
376m.1101-1 RCT to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in AAA_Dawson, ejeves.pdf | 339.28Kb | January 14 2011 |
376m.1101-2 Comment_Vega de Cinega, ejves.pdf | 87.06Kb | January 14 2011 |
388e.1101-Management of non-GCA of the superficial temporal artery_Labropoulos, jvs.pdf | 309.38Kb | January 14 2011 |
418.1101-Controlled trial of Prostacyclin and rt-PA in the Tt of severe frosbite_Cauchy, nejm.pdf | 394.92Kb | January 14 2011 |
421H.1101-Long term FU of Upper and Lower exrtremity vasculitis related to GCA (36 cases)_Assie, Medicine.pdf | 720.13Kb | January 14 2011 |
464c.1101-A typical case of nutcracker phenomenon_Marone, jvs.pdf | 93.54Kb | January 14 2011 |
620.1101-Prophylaxis for VTE, Guidelines translated for the clinician_Stashenko, JTT.pdf | 200.32Kb | January 14 2011 |
622ot.1011-Enoxaparin vs Dabigatran or Rivaroxaban after THR or TKR. Separate pooled analysis ..._Huisman, CCVQO.pdf | 525.27Kb | January 14 2011 |